BURLINGTON, Mass., April 26 /PRNewswire/ -- LeMaitre Vascular, Inc. today announced that it has filed a registration statement with the United States Securities and Exchange Commission for an initial public offering of its common stock. The company intends to use the net proceeds of this proposed offering primarily to hire additional sales personnel, fund clinical studies and expand its manufacturing and research and development capabilities. Application has been made for quotation of the company’s common stock on the Nasdaq National Market under the symbol “LMAT.”
Goldman, Sachs & Co. will act as sole book-running manager, and CIBC World Markets, Cowen & Company and JMP Securities will act as co-managers, for the proposed offering.
The proposed offering will be made only by means of a prospectus. When available, copies of the preliminary prospectus related to the proposed offering may be obtained from Goldman, Sachs & Co., 85 Broad Street, New York, NY 10004, Attn: Prospectus Department via fax at (212) 902-9316 or e-mail at prospectus-ny@ny.email.gs.com.
A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release does not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
LeMaitre Vascular develops, manufactures and markets medical devices for the treatment of peripheral vascular disease. The company’s principal executive offices are located at 63 Second Avenue, Burlington, Massachusetts 01803.
LeMaitre Vascular, Inc.
CONTACT: Sandra Millar, Media Relations, or Aaron Grossman, InvestorRelations, both of LeMaitre Vascular, Inc., +1-781-221-2266
Web site: http://www.lemaitre.com//
